entertainment -WSS

entertainment

author：focus 2025-09-28 02:31:43 - browse：3

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Kaiser Permanente unions announce official strike date

WSS

How the Dana

Medicaid, Medicare dual

How one patient went off dialysis — and others can too

How to ethically and practically extend health care to all

Alnylam reports growth in sales of rare disease treatments

2 officers injured in shooting in Orlando, police say

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Novavax promises a turnaround & Lilly roils the obesity market

FDA approves Sage Therapeutics’ rapid

Alkermes shareholders re

Flint parents haunted by uncertainty, fears of lead poisoning

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Would Medicare drug price negotiations stall in a shutdown?

Peter Hotez and the public health issue of online harassment

Inequities make cancer less preventable for women: report

leisure time

Flint parents haunted by uncertainty, fears of lead poisoning

The cancer stories no one wants to hear

Pharma showers House GOP doctor with campaign cash

Did you have Obamacare on your GOP debate bingo card?

Alnylam reports growth in sales of rare disease treatments

Florida officials tell state schools to teach AP Psychology 'in its entirety'

focus

Wikipedia

knowledge

knowledge